| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-05 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-05 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |